The Centers for Medicare & Medicaid Services (CMS) has announced it will fully resume laboratory survey activity — as required by the Clinical Laboratory Improvement Amendments (CLIA) — following a suspension in enforcement action during the COVID-19 public health emergency (PHE).
This content is restricted to members.
